In contrast, in locally advanced HNSCC patients with low PD-L1 expression, the lack of a prominent immunosuppressive environment allows radiotherapy to achieve better therapeutic outcomes. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.